Dr Zach Moore presents results of a study on MALT involving the dura Brandon Imber Memorial Sloan Kettering Radiation Oncology

See editorial here! #ASTRO24 astro.org/meetings-and-e…

Effective cytoreduction in the bridging period can significantly improve outcomes for those planned for CAR T cells - radiotherapy ☢️ is a particularly effective tool for highest risk pts! Clinical Cancer Research Memorial Sloan Kettering Radiation Oncology Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Memorial Sloan Kettering Cancer Center ILROG Team pubmed.ncbi.nlm.nih.gov/39259292/

Effective cytoreduction improves outcomes for CAR T cell patients - Brandon Imber oncodaily.com/insight/brando… #AACR #Cancer #MSK #OncoDaily #Oncology #PatientOutcomes #Radiotherapy #RadOnc #Medicine #Health #MedEd #MedX #MedNews

Bridging RT pre- and post-LD CAR-T Brandon Imber #ASH24: - 6 pts, 50% adv-stage - 1 G5 CRS AE after axi-cel - of 5 survivors, all CMR w/ continued remission at mFU 12 mo - CAR-T expansion measured Fascinating approach: sensitize NHL cells w/ RT right before CAR infusion. #lymsm

Featured today by MSK Library: Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020 #MedicalStudy #CNSLymphoma #Relapse #LongitudinalAnalysis #Patients #CancerDiagnosis #OncologyResearch

In a large cohort of PCNSL patients with long follow-up, Kathryn Ries Tringale, Michael Scordo, @Brandon_Imber found cerebral atrophy rates were similar across consolidation strategies suggesting similar neurotoxicity. Read it in the #RedJournal: tinyurl.com/redtring

The Illustrated Post: Symptomatic PSMA PET–positive radionecrosis after multimodality brain metastasis–directed treatment including ¹⁷⁷Lu-PSMA-617. ow.ly/5sra50Vjv05 #RPTherapy #NuclearMedicine #BrainMetastases Simone Krebs Laboratory Brandon Imber @mskCancerCenter

Phase I Study of split course bridging RT prior to CAR-T cell therapy for R/R B- cell lymphoma: citoreduction and immune priming. Impressive results! Brandon Imber #ICML18

We stan bridging RT before CAR! #18ICML - 116 pts with comprehensive RT to all PET avid sites - higher RT dose = less post-CAR G3+ CRS - higher LDH after RT = more G3+ CRS/ICANS Who else is using multisite bridging RT before CAR? #lymsm #tcellrx

Amazing work Bea Fregonese presenting our initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke

Standing room only for Nikhil Mankuzhy, MD oral on PET-response adapted 4 Gy for potentially curable indolent lymphomas! Great job pushing the frontier of RT! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center ILROG Team #18ICML

Outstanding presentation from PGY5 Alexi Dreyfuss showing the community that ISRT and pembro can be a powerful, transplant sparing option for localized recurrent Hodgkin lymphoma! Great work! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center #18ICML ILROG Team

Double trouble! Congrats to Rosh on his important work showing that bridging RT prior to CAR T cells is safe and probably needs greater personalization by tumor genetics. Great work! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center #18ICML

Congrats to Alok Deshane on his #18ICML poster seeking to modernize our understanding of which mantle cell lymphoma patients benefit from radiotherapy💥💥Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center

Amazing work by Bea Fregonese presenting initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke Memorial Sloan Kettering Radiation Oncology ILROG Team

Beyond proud of our Memorial Sloan Kettering Radiation Oncology hematology research team! Exciting research at the forefront of all aspects of #18ICML!! Hopefully the Lago view makes up for all the hard work 😉 Memorial Sloan Kettering Cancer Center